期刊论文详细信息
Skin Therapy Letter-Family Practice Edition
New Developments in Hormonal Therapy for Acne
关键词: Acne vulgaris;    oral contraceptives;    ethinyl estradiol;    cyproterone acetate;    drospirenone;    norgestimate;    levonorgestrel;   
DOI  :  
学科分类:医学(综合)
来源: Skin Therapy Letter-Family Practice Edition
PDF
【 摘 要 】

Oral contraceptives (OCs) are a valuable option for the treatment of women with acne. The use of OCs can be considered across the spectrum of acne disease severity in women. In Canada, three preparations are approved for mild-to-moderate acne, and a fourth is indicated for severe acne. These formulations contain estrogen in the form of ethinyl estradiol and a progestin. In Canada, the most recently approved OC is ethinyl estradiol 0.03mg and drospirenone 3mg (Yasmin®, Bayer). With the accumulating evidence on the efficacy and safety of drospirenone-containing hormonal preparations, this formulation provides dermatologists with a new treatment option for acne and other hyperandrogenic disorders.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912040572898ZK.pdf 523KB PDF download
  文献评价指标  
  下载次数:13次 浏览次数:4次